Antophar SRL
2.5 FTEAntophar reported total assets of €1.55m at the end of the 2025 financial year (annual accounts filed with the NBB on 12 May 2026), with 2.5 full-time equivalents.
The score of Antophar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -10 % Total assets +13 % Headcount (avg FTE) -11 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Antophar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Antophar's financial analysis
- Solvency75.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Antophar
Antophar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0428.091.979
- VAT number
- BE0428091979
- Peppol
- Registered · 0208:0428091979 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Dec 1985
- Registered office
- 7640 Antoing
- Size
- Micro · 2.5 FTE
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Antophar (SRL) has been based in Antoing since 1985, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 87,206 € and equity of €1.18m; its revenue is not published. With 2.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 75.8%, above the median of its sector (41.5%).
Companies similar to Antophar
Companies in the same business, of comparable size and area, outside its group.
- Mariacor Retail sale of pharmaceutical products Saint-Léger (Lux.) · balance sheet €1.55m
- Apotheek Obus - DE Galan Retail sale of pharmaceutical products Aalst · balance sheet €1.55m
- Pharma-Louve Retail sale of pharmaceutical products Seneffe · balance sheet €1.55m
- Lenapharm Pharmacie Retail sale of pharmaceutical products Ixelles · balance sheet €1.56m
- Pharmacie Haufroid Retail sale of pharmaceutical products Villers-le-Bouillet · balance sheet €1.56m
- Geassocieerde Apotheek Markgrave Retail sale of pharmaceutical products Antwerp · balance sheet €1.56m
- Sophade Retail sale of pharmaceutical products Wavre · balance sheet €1.54m
- Apoteek Goossens Retail sale of pharmaceutical products Wemmel · balance sheet €1.56m
Frequently asked questions about Antophar
What is the revenue of Antophar?
Antophar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Antophar?
In Belgium, the VAT number is the company number prefixed with BE: BE0428091979 for Antophar, if the company is VAT-registered. Its company number (CBE) is 0428.091.979.
Where is the registered office of Antophar?
According to the CBE register, the registered office of Antophar is in 7640 Antoing.
What is the equity of Antophar?
At the close of the 2025 financial year, the equity of Antophar amounts to 1,176,913 €, a solvency of 75.8% of total assets.
How many people work at Antophar?
2.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Antophar?
The register lists 5 active mandates at Antophar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Antophar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →